The ipsogen BCR-ABL1 Mbcr RGQ RT-PCR Kit is a quantitative in vitro diagnostic test for the
measure of the BCR-ABL1 fusion gene b3a2 (e14a2) and b2a2 (e13a2) transcripts in total
RNA extracted from whole blood.
The ipsogen BCR-ABL1 Mbcr RGQ RT-PCR Kit is intended to monitor deep molecular response
in patients diagnosed with chronic phase Philadelphia chromosome positive (Ph+) p210
chronic myeloid leukemia (CML).
It is calibrated against the World Health Organization (WHO) International Genetic Reference
Panel.